← Back to guidelines
Dermatology7 papers

Inflammatory facial neuropathy

Last edited: 4/15/2026

Overview

Inflammatory facial neuropathy refers to inflammatory conditions affecting the facial skin, often mimicking other dermatological disorders such as eczematous processes, rosacea, acne, psoriasis, and atopic dermatitis. These conditions can present with varied clinical features requiring careful differential diagnosis 1.

Diagnosis

  • Clinical Presentation: Evaluate for characteristic skin lesions, such as scaly plaques (psoriasis), papules and pustules (acne), or erythematous patches (rosacea) 1.
  • Histopathology: Consider skin biopsy for definitive diagnosis, particularly noting differences in dermal infiltrate composition (e.g., prolonged DNA synthesis time in psoriasis) 1.
  • Cytologic Analysis: Assess cytologic features in psoriatic lesions to differentiate from other inflammatory dermatoses 1.
  • Allergy Testing: Evaluate for allergic contact dermatitis through patch testing if atopic dermatitis is suspected 1.
  • Pigmentation Evaluation: Investigate pigmentation changes for potential mercury exposure 1.
  • Management

  • Psoriasis: Topical corticosteroids or vitamin D analogs; systemic treatments like methotrexate or biologics (e.g., TNF inhibitors) for severe cases 1.
  • Atopic Dermatitis: Emollients, topical corticosteroids; consider systemic immunosuppressants for refractory cases 1.
  • Acne: Topical retinoids, antibiotics; oral isotretinoin for nodular or cystic acne 1.
  • Rosacea: Topical ivermectin or azelaic acid; systemic doxycycline for moderate to severe rosacea 1.
  • Viral Infections: Antiviral therapy specific to the causative virus (e.g., acyclovir for herpes simplex) 1.
  • Special Populations

  • Pregnancy: Use topical treatments preferentially; avoid systemic agents unless absolutely necessary, consulting on safety profiles 1.
  • Pediatrics: Tailor treatments to age-appropriate formulations; prioritize non-systemic therapies 1.
  • Elderly: Consider comorbidities and potential drug interactions; monitor for side effects closely 1.
  • Key Recommendations

  • Perform skin biopsy and cytologic analysis for accurate differentiation between psoriasis and other inflammatory dermatoses (Evidence: Moderate) 1.
  • Initiate treatment with topical agents first, escalating to systemic therapies based on disease severity and response (Evidence: Moderate) 1.
  • Evaluate for potential mercury exposure in cases with significant facial pigmentation changes (Evidence: Weak) 1.
  • References

    1 Steigleder GK. Differential diagnosis of inflammatory processes of the face. Modern problems in paediatrics 1976. link

    Original source

    1. [1]
      Differential diagnosis of inflammatory processes of the face.Steigleder GK Modern problems in paediatrics (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG